From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics
- DOI
- 10.1016/j.omtm.2025.101613
- Published
- 2025-12
- Container
- Molecular Therapy Methods & Clinical Development
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.omtm.2025.101613,
title = {From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics},
author = {John Gostage and Daniel A. Domingo-Lopez and Ruth Tarpey and Garry P. Duffy and Ruth E. Levey},
year = {2025},
journal = {Molecular Therapy Methods \& Clinical Development},
doi = {10.1016/j.omtm.2025.101613},
url = {https://doi.org/10.1016/j.omtm.2025.101613}
}RIS
TY - JOUR TI - From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics AU - John Gostage AU - Daniel A. Domingo-Lopez AU - Ruth Tarpey AU - Garry P. Duffy AU - Ruth E. Levey PY - 2025 JO - Molecular Therapy Methods & Clinical Development DO - 10.1016/j.omtm.2025.101613 UR - https://doi.org/10.1016/j.omtm.2025.101613 ER -
APA
Gostage, J., Domingo-Lopez, D. A., Tarpey, R., Duffy, G. P., & Levey, R. E. (2025). From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics. Molecular Therapy Methods & Clinical Development. https://doi.org/10.1016/j.omtm.2025.101613
Source records
- crossref · retrieved 2026-09-27T16:06:46.009Z